celiprolol has been researched along with labetalol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Rahn, KH | 2 |
| Sponer, G; Strein, K | 1 |
| Opie, LH | 1 |
| Imai, S; Ishibashi, T; Jin, H; Mitomi, A; Nakazawa, M; Ohta, H; Tatebe, S | 1 |
| Proegler, M; Schneider, H | 1 |
| Lefflerová, K; Widimský, J | 1 |
4 review(s) available for celiprolol and labetalol
| Article | Year |
|---|---|
Clinical experience with dual-acting drugs in hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Propanolamines; Vasodilator Agents | 1992 |
Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Celiprolol; Coronary Disease; Heart Failure; Hemodynamics; Humans; Labetalol; Propanolamines; Vasodilator Agents; Ventricular Function, Left | 1990 |
Antihypertensive compounds with combined actions.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Propanolamines | 1987 |
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Middle Aged; Pindolol; Propanolamines | 1988 |
5 other study(ies) available for celiprolol and labetalol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Mechanism of smooth muscle contraction: relevance to safety of beta-adrenergic blockade in hypertensive patients with reversible chronic obstructive airways disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Bronchi; Calcium Channel Blockers; Calmodulin; Celiprolol; Cyclic AMP; Heart; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Models, Biological; Muscle Contraction; Muscle, Smooth; Myosins; Phosphorylation; Propanolamines | 1986 |
Partial agonist activity of celiprolol as assessed in conscious unrestrained dogs in comparison with those of pindolol and labetalol.
Topics: Adrenergic alpha-Agonists; Animals; Celiprolol; Dogs; Dose-Response Relationship, Drug; Heart; Hemodynamics; Labetalol; Male; Pindolol; Propanolamines; Sympathetic Nervous System | 1989 |
Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue.
Topics: Adrenergic beta-Antagonists; Atenolol; Celiprolol; Female; Humans; In Vitro Techniques; Labetalol; Maternal-Fetal Exchange; Placenta; Pregnancy; Propanolamines; Propranolol; Timolol | 1988 |